Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm infants

T Michael O'Shea, Bhavesh Shah, Elizabeth N Allred, Raina N Fichorova, Karl C K Kuban, Olaf Dammann, Alan Leviton, ELGAN Study Investigators, T Michael O'Shea, Bhavesh Shah, Elizabeth N Allred, Raina N Fichorova, Karl C K Kuban, Olaf Dammann, Alan Leviton, ELGAN Study Investigators

Abstract

Neonatal inflammation is associated with perinatal brain damage. We evaluated to what extent elevated blood levels of inflammation-related proteins supplement information about the risk of impaired early cognitive function provided by inflammation-related illnesses. From 800 infants born before the 28th week of gestation, we collected blood spots on days 1, 7 and 14, for analysis of 25 inflammation-related proteins, and data about culture-positive bacteremia, necrotizing enterocolitis (Bell stage IIIb), and isolated perforation of the intestine, during the first two weeks, and whether they were ventilated on postnatal day 14. We considered a protein to be persistently or recurrently elevated if its concentration was in the top quartile (for gestational age and day blood was collected) on two separate days one week apart. We assessed the children at 2 years of age with the Bayley Mental Development Index (MDI). The combinations of NEC and ventilation on day 14, and of bacteremia and ventilation on day 14 consistently provided information about elevated risk of MDI <55, regardless of whether or not a variable for an elevated protein concentration was included in the model. A variable for a persistently or recurrently elevated concentration of each of the following proteins provided additional information about an increased risk of MDI <55: CRP, SAA, IL-6, TNF-alpha, IL-8, MIP-1beta, ICAM-1, E-SEL, and IGFBP-1. We conclude that elevated blood concentrations of inflammation-related proteins provide information about the risk of impaired cognitive function at age 2 years that supplements information provided by inflammation-associated illnesses.

Conflict of interest statement

Conflict of interest statement:

All authors declare that there are no conflicts of interests.

None of the authors has any financial issue or conflict of interest to disclose

Copyright © 2013 Elsevier Inc. All rights reserved.

Figures

Figure 1
Figure 1
Four models of the interrelationships among an inflammation stimulus (one or more inflammation-related illnesses), and inflammation response, and an indicator of brain damage

Source: PubMed

3
S'abonner